Mandate

DFDS and C.PORTS roll-on/roll-off terminal in Gothenburg

October 21, 2010

DFDS and C.PORTS SA have jointly acquired Älvsborg Ro/Ro AB and will take over the operation of the roll-on/roll-off terminal in Gothenburg harbour. In connection herewith a 25 year licence agreement has been entered into between Älvsborg and Gothenburg Harbour concerning the use of the terminal and associated infrastructure.

The transaction entails that two of the harbour’s largest customers will take over the roll-on/roll-off terminal provided that the relevant competition authorities give their consent. The transaction is part of the ongoing privatisation of the terminal operations in Gothenburg Harbour. The roll-on/roll-off terminal is the first part of the operation to be privatised and this will be followed by the car terminal and ferry terminal. Gothenburg Harbour is the largest harbour in the Nordic region. DFDS is listed on NASDAQ OMX Copenhagen and conducts, among other things, terminal operations and container, roll-on/roll-off and passenger freight operations. C.PORTS is a Belgian company which conducts terminal operations and is a part of the Luxemburg based sea freight and harbour group, CLdN.

Vinge is advising Gothenburg Harbour in the privatisation process. Vinge’s team consists of responsible partner Fredrik Sonander and partner Charlotte Johansson and associate Lisa Askbrink as well as a large number of colleagues within the M&A, employment, environmental, IT and real estate practice groups.


 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026